Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing–remitting multiple sclerosis
Authors:
- Natascha Helena BeyerNBNatascha Helena Beyer
- Angelika LuekingALAngelika Lueking
- Axel KowaldAKAxel Kowald
- Jette Lautrup FrederiksenJFJette Lautrup Frederiksen
- Niels H.H. HeegaardNHNiels H.H. Heegaard
- 1 January 2012
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 242 (1-2) , 26-32
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Lipid autoreactivity in multiple sclerosisMedical Hypotheses, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosisProceedings of the National Academy of Sciences, 2008
- Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosisScandinavian Journal of Clinical and Laboratory Investigation, 2007
- Prevalence of Diabetes in Patients With Multiple SclerosisDiabetes Care, 2006
- Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patientsAnnals of Neurology, 2004
- Retinal Antigens Are Recognized by Antibodies Present in Sera of Patients with Multiple SclerosisOphthalmic Research, 2004
- Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosisThe FASEB Journal, 2003
- Cerebrospinal fluid myelin basic protein-like material in acute monosymptomatic optic neuritisActa Neurologica Scandinavica, 1996